• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research.

作者信息

Reilly J J, Workman P

机构信息

University of Glasgow Department of Human Nutrition, Yorkhill Hospitals, UK.

出版信息

Cancer Chemother Pharmacol. 1994;34(1):3-13. doi: 10.1007/BF00686105.

DOI:10.1007/BF00686105
PMID:8174199
Abstract
摘要

相似文献

1
Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research.身体成分是抗癌药物药代动力学中的一个重要变量吗？综述及进一步研究建议。
Cancer Chemother Pharmacol. 1994;34(1):3-13. doi: 10.1007/BF00686105.
2
A review of body composition and pharmacokinetics in oncology.肿瘤患者的身体成分和药代动力学综述。
Expert Rev Clin Pharmacol. 2017 Sep;10(9):947-956. doi: 10.1080/17512433.2017.1347503. Epub 2017 Jul 5.
3
Influence of lean body weight on anticancer drug clearance.瘦体重对抗癌药物清除率的影响。
Clin Pharmacol Ther. 2009 Jan;85(1):23; author reply 24. doi: 10.1038/sj.clpt.6100511. Epub 2008 Feb 20.
4
General aspects of cancer chemotherapy in the aged.老年癌症化疗的一般情况。
Adv Exp Med Biol. 1993;330:271-86. doi: 10.1007/978-1-4615-2926-2_19.
5
Pharmacokinetics in the child.儿童的药代动力学。
Environ Health Perspect. 1994 Dec;102 Suppl 11(Suppl 11):111-7. doi: 10.1289/ehp.94102s11111.
6
Interpatient pharmacokinetic and pharmacodynamic variability of carrier-mediated anticancer agents.载体介导的抗癌药物的患者间药代动力学和药效学变异性。
Clin Pharmacol Ther. 2012 May;91(5):802-12. doi: 10.1038/clpt.2012.12.
7
Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.
Clin Pharmacokinet. 1989 Jun;16(6):327-36. doi: 10.2165/00003088-198916060-00001.
8
Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics.基于肿瘤的药代动力学对比基于血液的药代动力学，对抗癌药物而言具有更重大的意义。
Clin Pharmacol Ther. 2004 Nov;76(5):508; author reply 508-9. doi: 10.1016/j.clpt.2004.08.012.
9
Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review).儿科患者中抗癌药物的临床药代动力学和药效学（综述）
Anticancer Res. 1993 Sep-Oct;13(5C):1795-808.
10
[Usefulness of a pharmacokinetic approach for clinical antineoplastic chemotherapy evaluation].[药代动力学方法在临床抗肿瘤化疗评估中的应用价值]
Bull Cancer. 1999 Apr;86(4):341-4.

引用本文的文献

1
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.非转移性结肠癌诊断时的肌肉量以及辅助性FOLFOX化疗的早期停药、延迟和剂量减少：C-SCANS研究
Cancer. 2017 Dec 15;123(24):4868-4877. doi: 10.1002/cncr.30950. Epub 2017 Sep 7.
2
Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer.生殖细胞癌患者高剂量卡铂的个体化给药策略
Br J Cancer. 2003 Sep 1;89(5):787-94. doi: 10.1038/sj.bjc.6601215.
3
Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer.

本文引用的文献

1
Body composition measurements for nutrition research.用于营养研究的身体成分测量
Nutr Res Rev. 1988 Jan;1(1):115-24. doi: 10.1079/NRR19880010.
2
Age differences in the water content of the body as related to basal oxygen consumption in males.男性身体水分含量与基础氧消耗的年龄差异。
J Gerontol. 1963 Jan;18:1-8. doi: 10.1093/geronj/18.1.1.
3
Individualizing dosing of cancer chemotherapy.癌症化疗的个体化给药
决定晚期结直肠癌患者化疗毒性的危险因素。
Drug Saf. 2000 Oct;23(4):255-78. doi: 10.2165/00002018-200023040-00001.
4
Practical treatment guide for dose individualisation in cancer chemotherapy.癌症化疗剂量个体化实用治疗指南。
Drugs. 1998 Dec;56(6):1019-38. doi: 10.2165/00003495-199856060-00006.
5
What is the effect of adjusting epirubicin doses for body surface area?根据体表面积调整表柔比星剂量会产生什么效果？
Br J Cancer. 1998 Sep;78(5):662-6. doi: 10.1038/bjc.1998.556.
6
Malnutrition as a prognosis factor in lymphoblastic leukemia: a multivariate analysis.营养不良作为淋巴细胞白血病的预后因素：一项多变量分析。
Arch Dis Child. 1995 Jan;72(1):98. doi: 10.1136/adc.72.1.98.
7
Determination of body composition from skinfold thickness: a validation study.通过皮褶厚度测定身体成分：一项验证研究。
Arch Dis Child. 1995 Oct;73(4):305-10. doi: 10.1136/adc.73.4.305.
Semin Oncol. 1993 Feb;20(1):30-42.
4
The relevance of pharmacology in clinical oncology practice. Pharmacology is relevant.
Ann Oncol. 1993 Jun;4(6):463-5. doi: 10.1093/oxfordjournals.annonc.a058552.
5
Hydration of the fat-free body mass in children and adults: implications for body composition assessment.儿童和成人无脂肪体重的水合作用：对身体成分评估的影响。
Am J Physiol. 1993 Jul;265(1 Pt 1):E88-95. doi: 10.1152/ajpendo.1993.265.1.E88.
6
Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations.
Cancer Chemother Pharmacol. 1993;32(6):411-8. doi: 10.1007/BF00685883.
7
Does weight for height have prognostic significance in children with acute lymphoblastic leukemia?身高体重指标对急性淋巴细胞白血病患儿有预后意义吗？
Am J Pediatr Hematol Oncol. 1994 Aug;16(3):225-30. doi: 10.1097/00043426-199408000-00007.
8
Measuring the body composition of elderly subjects: a comparison of methods.
Br J Nutr. 1994 Jul;72(1):33-44. doi: 10.1079/bjn19940007.
9
Comparison of methods of estimating body fat in normal subjects and cancer patients.
Am J Clin Nutr. 1981 Dec;34(12):2839-47. doi: 10.1093/ajcn/34.12.2839.
10
Body composition of reference children from birth to age 10 years.从出生到10岁的参考儿童的身体组成。
Am J Clin Nutr. 1982 May;35(5 Suppl):1169-75. doi: 10.1093/ajcn/35.5.1169.